About Asahi Kasei
Asahi Kasei is a company based in Tokyo (Japan) founded in 1931.. The company has 50,350 employees as of March 31, 2024. Asahi Kasei operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Tokyo, Japan
- Employees 50350 as on 31 Mar, 2024
- Stage Public
-
Sectors
Chemicals & MaterialsHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Asahi Kasei Corporation
-
Annual Revenue
$19.37 B (USD)9.06as on Mar 31, 2024
-
Net Profit
$860.15 M (USD)208.17as on Mar 31, 2024
-
EBITDA
$2.54 B (USD)23.25as on Mar 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
50350
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Asahi Kasei
Asahi Kasei is a publicly listed company on the TSE with ticker symbol 3407 in Japan, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Asahi Kasei
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Grant - Asahi Kasei | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Asahi Kasei
Asahi Kasei has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asahi Kasei
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asahi Kasei
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asahi Kasei Comparisons
Competitors of Asahi Kasei
Asahi Kasei operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Asahi Kasei
Frequently Asked Questions about Asahi Kasei
When was Asahi Kasei founded?
Asahi Kasei was founded in 1931 and raised its 1st funding round 84 years after it was founded.
Where is Asahi Kasei located?
Asahi Kasei is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Who is the current CEO of Asahi Kasei?
Hideki Kobori is the current CEO of Asahi Kasei.
How many employees does Asahi Kasei have?
As of Mar 31, 2024, the latest employee count at Asahi Kasei is 50,350.
What is the annual revenue of Asahi Kasei?
Annual revenue of Asahi Kasei is $19.37B as on Mar 31, 2024.
What does Asahi Kasei do?
Asahi Kasei was established in 1931 in Tokyo, Japan, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Focus is placed on producing liquid, solid, and injectable drug formulations for clients. Services encompass development and manufacturing processes tailored to pharmaceutical needs. Leadership is provided by President and CEO Hideki Kobori, with headquarters maintained in Tokyo.
Who are the top competitors of Asahi Kasei?
Asahi Kasei's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Is Asahi Kasei publicly traded?
Yes, Asahi Kasei is publicly traded on TSE under the ticker symbol 3407.
Who are Asahi Kasei's investors?
Asahi Kasei has 1 investor. Key investors include European Union.
What is Asahi Kasei's ticker symbol?
The ticker symbol of Asahi Kasei is 3407 on TSE.